Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
This study is ongoing, but not recruiting participants.
Onyx Therapeutics, Inc.
Information provided by (Responsible Party):
Amgen ( Onyx Therapeutics, Inc. )
First received: April 10, 2013
Last updated: January 20, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||October 2017|
|Estimated Primary Completion Date:||July 2017 (Final data collection date for primary outcome measure)|